Both Rapid News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Both Rapid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Both Rapid Today - Breaking & Trending Today

Relmada Therapeutics Announces Efficacy and Safety Results from the Phase 3 Long-Term Study of REL-1017 in Major Depressive Disorder

Published: September 20, 2023

Patients newly treated with REL-1017 for up to one year experienced rapid, clinically meaningful, and sustained improvements in depressive symptoms and associated functional impairmentLong-term...

Source: marketscreener.com

Related Topics:

Cedric OgormanTim MccarthySecurities ExchangeClinical Research ProgramRelmada Therapeutics IncPrnewswire Relmada Therapeutics IncCorporate CommunicationsMajor Depressive DisorderCedrico GormanChief Medical OfficerSustained Substantial ImprovementClinical ResponseBoth RapidClinical RemissionScale Also Showed Clinical ImprovementClinical Global ImpressionFunctional ImpairmentSheehan Disability ScaleHamilton Anxiety Rating ScaleTerm SafetyRelmada TherapeuticsPrivate Securities Litigation Reform ActSecurities ActSecurities Exchange Act